Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa

BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Christina, Agosta, Patrina, McKee, Christina, Walker, Keegan, Mazzella, Matteo, Alamri, Ali, Svinarich, David, Chaudhry, G. Rasul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994263/
https://www.ncbi.nlm.nih.gov/pubmed/35395806
http://dx.doi.org/10.1186/s13287-022-02828-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994263/
https://www.ncbi.nlm.nih.gov/pubmed/35395806
http://dx.doi.org/10.1186/s13287-022-02828-w

Ejemplares similares